More power means more responsibility during the onboarding phase
At the same time, the company is dealing with thousands of lawsuits from people who say they were harmed by these drugs, and new cases are still being filed
Grunberger C, Chang A, Garcia Soria G, et al
Social media and online communities have thrust these tales into the limelight and brought more people to think about this drug, even when it does not yet have the stamp of approval from health agencies
Health Canada needs to consider each company's application to make and sell generic versions of the injectable medication, known as a biosimilar
The premise, Noom says, is simple: microdoses are easier to tolerate and maintain, while microhabits, the behavioral layer of Nooms program, reinforce long-term outcomes